Page last updated: 2024-10-31

metyrapone and Diseases in Twins

metyrapone has been researched along with Diseases in Twins in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Diseases in Twins: Disorders affecting TWINS, one or both, at any age.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenfield, RL1
Root, AW1
Bongiovanni, AM1
Eberlein, WR1
Sizonenko, PC1
Paunier, L1
Vallotton, B1
Cuendet, GS1
Zahnd, G1
Marliss, EB1

Other Studies

2 other studies available for metyrapone and Diseases in Twins

ArticleYear
Idiopathic anterior hypopituitarism in one of monozygous twins.
    The Journal of pediatrics, 1967, Volume: 70, Issue:1

    Topics: Adolescent; Diseases in Twins; Dwarfism, Pituitary; Female; Gonadotropins; Humans; Karyotyping; Mety

1967
Response to 2-deoxy-D-glucose and to glucagon in "ketotic hypoglycemia" of childhood: evidence for epinephrine deficiency and altered alanine availability.
    Pediatric research, 1973, Volume: 7, Issue:12

    Topics: Adrenocorticotropic Hormone; Alanine; Blood Glucose; Child; Child, Preschool; Diseases in Twins; Epi

1973